Check with your chosen provider about availability in your specific state
Consequently, caution should be exercised when interpreting findings from large EHR studies
Someone with good blood sugar control needing appetite suppression might do well on GLP-1 medications
Our results highlight the opportunity for pharmacogenetics and precision medicine approaches applied to GLP1 medication
Engineered to activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, Retatrutide has shown promising preclinical results in studies of metabolic regulation, weight management, and glycemic control
They work by slowing digestion, reducing appetite, and promoting feelings of fullness